OMA Guidelines Bundle

Obesity-Related Diseases - OMA Obesity Algorithm 2023

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349827

Contents of this Issue

Navigation

Page 23 of 23

Abbreviations ALT, alanine transaminase; AST, aspartate transaminase; AT, adipose tissue; BNP, B-type natriuretic peptide; CETP, cholesteryl ester transfer protein; CVD, cardiovascular disease; CVOT, cardiovascular outcome trial; FFA, f ree fatty acids; GIP, glucose-dependent insulinotropic polypeptide; GLP-1 RA, glucagon-like peptide-1 receptor agonist; HFpEF, heart failure with preserved ejection f raction; HDL, high density lipoprotein; HDL-C, high density lipoprotein cholesterol; HSL, hormone sensitive lipase; IL-6, interleukin-6; LDL, low density lipoprotein; LPL, lipoprotein lipase; MACE, major adverse cardiovascular events; MRI-PDFF, magnetic resonance imaging proton density fat f raction; MRS, magnetic resonance spectroscopy; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; PCOS, polycystic ovary syndrome; RAAS, renin-angiotensin aldosterone system; ROS, reactive oxygen species; SELECT, semaglutide in patients with obesity; SGLT, sodium glucose transporter; SOUL, semaglutide in patients with type 2 diabetes; T2DM, type 2 diabetes mellitus; TGs, triglycerides; VLDL, very low-density lipoproteins Source Bays HE, McCarthy W, Burridge K, Tondt J, Karjoo S, Christensen S, Ng J, Golden A, Davisson L, Richardson L. Obesity Algorithm eBook, presented by the Obesity Medicine Association. www.obesityalgorithm.org. 2023. https://obesitymedicine.org/obesity-algorithm. (Accessed = January 2023) 1258 Upsala Rd Sanford, FL 32771 TEL: 407.878.7606 FAX: 407.878.7611 Copyright © 2023 All rights reserved Obesity Medicine Association 7173 S. Havana St #600–130 Centennial, CO 80112 TEL: 303.770.2526 OMAOBEAD01232 Disclaimer is resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers aer consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

Articles in this issue

Links on this page

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases - OMA Obesity Algorithm 2023